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Identification of the early programming window for masculinization of the reproductive tract in rats. Internal and external genitalia from male rats 
exposed in utero to flutamide in EW (E15.5–E17.5), MW (E17.5–E19.5), LW (E19.5–E21.5), or FW (E15.5–E21.5) were examined at P25. (A) 
Schematic diagram of normal masculinization of the indifferent reproductive tissues into their derivative tissues. EW or MW flutamide exposure 
prevents prostate (B) and seminal vesicle (C) formation in almost all males at P25, while LW flutamide does not prevent prostate or seminal 
vesicle formation in any males. Ventral prostates (D) and seminal vesicles (E) are significantly smaller in the few EW and MW flutamide-exposed 
males that had any tissue present. AGD (F) and phallus length (G) are reduced to near female levels in EW and MW flutamide-exposed males 
at P25. Values are mean ± SEM (n = 8–28 rats from 2–5 litters per treatment group). †P > 0.05 compared with female values; ***P < 0.001 com-
pared with control male values. Blue dotted line highlights mean male level; red dotted line highlights mean control female level.
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Reproductive congenital abnormalities can only be induced by impaired androgen action in the early programming window. Male rats exposed in 
utero to flutamide in EW (E15.5–E17.5), MW (E17.5–E19.5), LW (E19.5–E21.5), or FW (E15.5–E21.5) were examined at P25 for hypospadias 
and cryptorchidism. (A) Images of external genitalia in P25 males demonstrating normal AGD (line) and penis formation, with the urethral open-
ing (arrowhead) at the tip, and scrotal testes (S) in control males compared with reduced AGD, abnormal penis formation with a urethral opening 
at the base, and undescended testes in EW or FW flutamide-exposed males. Original magnification, ×1.4. (B) Note that EW or MW flutamide 
induced hypospadias, as evidenced in A by the slit-like opening on the ventral surface of the penis (arrow), while FW-flutamide exposure resulted 
in a phallus with a female phenotype. (C) Schematic diagram of the phases of normal testis descent. (D) Incidence of cryptorchidism, showing 
that it can only be induced by flutamide exposure during the EW. Reduced AGD predicted the severity of hypospadias (E) and the incidence of 
cryptorchidism (F), as well as correlating with reduced penis length (G). Values are mean ± SEM (n = 8–28 rats from 2–5 litters per treatment 
group). ***P < 0.001 compared with control male values.
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The early programming window also determines experimental masculin-
ization of the reproductive tract in female rats. Since AR is also expressed 





Androgen concentrations and AR expression in a representative target 
tissue during the programming and differentiation windows. (A) Fetal 
testicular testosterone concentration (ng per testis) increases in line 
with mean fetal body weight (dotted line) between E15.5 and E21.5; red 
dotted line represents mean ovarian testosterone concentrations from 
E17.5 females. Note that there was no significant increase in testicular 
testosterone concentrations at any age compared with values for the 
previous day. Values are mean ± SEM (n = 4–17). (B) AR (red) expres-
sion in urogenital tubercles in males and females at E17.5 and E21.5, 
showing that the AR expression pattern is comparable in males and 
females at both ages. The urogenital tubercle has already begun to dif-
ferentiate into a penis in the E21.5 male, as evidenced by the presence 
of the os bone (OS) and the corpus cavernosum (CC). Note also that 
the urethral folds have begun to fuse in the male to form the urethral 
seam (US; cytokeratin-stained, green), unlike in the female. U, urethra; 
TA, tunica albuginea; MB, membranous bone. Scale bar: 200 μm.
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Exposure to exogenous testosterone in utero cannot advance or enhance 








Characterization of the windows of androgen action on phallus develop-
ment during fetal life. Our flutamide studies showed that the only 



















The early programming window determines experimental masculinization of the reproductive tract in female rats. Reproductive tracts from female 
rats exposed in utero to testosterone in EW (E15.5–E17.5), MW (E17.5–E19.5), LW (E19.5–E21.5), or FW (E15.5–E21.5) were examined at 
P17. Exposure to testosterone during the EW or MW resulted in formation of a ventral prostate (A), while exposure to testosterone during the 
EW induced seminal vesicle formation (B) and increased AGD in females to a male length (C). Exposure to testosterone during any time window 
increased phallus length compared with that in control females, but not to a male length (D). Values are mean ± SEM (n = 8–21 rats from 2–5 
litters per treatment group). ***P < 0.001 compared with control male values; †P < 0.001 compared with control female values. Blue dotted line 
highlights mean control male level; red dotted line highlights mean control female level.
Downloaded on March 27, 2014.   The Journal of Clinical Investigation.   More information at  www.jci.org/articles/view/34241
research article













































































Exposure to exogenous testosterone in utero cannot advance or enhance development of the reproductive tract tissues in the male. Reproduc-
tive tracts from male rats exposed in utero to testosterone in EW (E15.5–E17.5), MW (E17.5–E19.5), LW (E19.5–E21.5) or FW (E15.5–21.5), 
compared with control male and female rats, were examined at P17. AGD (A), ventral prostate weight (B), and phallus length (C) were not 
increased in males after exposure to testosterone during any time window in fetal life. Values are mean ± SEM (n = 5–21 rats from 2–5 litters 
per treatment group). ***P < 0.001 compared with control male values. Blue dotted line highlights mean control male level; red dotted line 
highlights mean control female level.
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Characterization of windows of androgen action in phallus development during fetal life. Reproductive 
tracts were examined at P25 from male rats exposed to flutamide (A) or at P17 from female rats exposed 
to testosterone (B) in utero during EW (E15.5–E17.5), MW (E17.5–E19.5), LW (E19.5–E21.5), or FW 
(E15.5–E21.5), compared with control male and female rats. (A) Phallus weight was reduced in male 
rats by exposure to flutamide during any window between E15.5 and E21.5, compared with that in con-
trol males. (B) Testosterone exposure during any window between E15.5 and E21.5 increased phallus 
weight in female rats, compared with that in control females, but not with male weight. (C) Images of P25 
male penis histology showing that EW, but not LW, flutamide affected ossification of the os penis (arrow), 
indicated by the absence of osteoid cells (stained red by Goldner stain) in the os penis after exposure to 
EW flutamide. Note also the failure of the urethral folds to fuse in the EW flutamide penis (*), compared 
with the formation of a patent urethra in the control and LW flutamide male. Original magnification, ×20. 
Values are mean ± SEM (n = 5–28 rats from 2–5 litters per treatment group). ***P < 0.001 compared with 
control male values; †P < 0.001 compared with control female values. Blue dotted line highlights mean 
male level; red dotted line highlights mean female level.
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Schematic diagram illustrating the timing 
of male reproductive tract development in 
humans and rats in relation to testicular 
testosterone production/levels; timings 
are based on data in the literature (17–23, 
25, 26, 31). Note that wolffian ducts, 
urogenital sinus (UGS), and urogeni-
tal tubercle are present initially in both 
sexes. The time windows used for the 
present rat treatments are also shown. 
The masculinization programming win-
dow in rats occurs between E15.5 and 
E19.5. S.V., seminal vesicles.
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Explanations of classification of testis descent and penis morphology
Parameter	 Classification	 Description
Testis position Cryptorchid Testes located in the abdomen, inguinal (beside the bladder), or ectopic outside the  
   body cavity (e.g., in the femoral canal)
 Scrotal Testes located in the scrotum or found in the inguinal canal but could be pushed into  
   the scrotum
Phallus external morphology Normal male Urethral opening at the tip of the phallus; phallus long and cylindrical; obvious internal  
   90° S-shaped bend in the phallus
 Abnormal male Urethral opening at the tip of the phallus; phallus long and cylindrical; internal 90° 
   S-shaped bend not apparent in the phallus; phallus fused internally on the ventral  
   surface to the body wall
 Hypospadiac male Urethral opening on the ventral surface of the phallus or perineum; phallus long and  
   cylindrical; internal 90° S-shaped bend not apparent in the phallus
 Female phenotype Female urethral opening; phallus flat and wide; internal 90° S-shaped bend not apparent  
   in the phallus
Downloaded on March 27, 2014.   The Journal of Clinical Investigation.   More information at  www.jci.org/articles/view/34241
research article
























































































































Downloaded on March 27, 2014.   The Journal of Clinical Investigation.   More information at  www.jci.org/articles/view/34241
research article
































































Best Pract. Res. Clin. Endocrinol. Metab. 20:577–598.
  6. Sarafoglou, K., and Ostrer, H. 2000. Clinical review 
111: familial sex reversal: a review. J. Clin. Endocrinol. 
Metab. 85:483–493.









































Natl. Acad. Sci. U. S. A. 102:9802–9807.
  17. Siiteri, P.K., and Wilson, J.D. 1974. Testosterone for-
mation and metabolism during male sexual differ-




































 28. Welsh,  M.,  Saunders,  P.T.,  Marchetti,  N.I., 






























Downloaded on March 27, 2014.   The Journal of Clinical Investigation.   More information at  www.jci.org/articles/view/34241
research article
1490	 The	Journal	of	Clinical	Investigation      http://www.jci.org      Volume 118      Number 4      April 2008
  35. Stinnakre, M.G. 1975. Period of sensitivity to andro-
gens of the Wolff duct of the rat fetus [In French]. 



























































receptor  gene.  German  Collaborative  Intersex 
Study Group. Eur. J. Pediatr. 156:7–14.
  50. Gorski, R.A. 2002. Hypothalamic imprinting by 
gonadal  steroid hormones. Adv. Exp. Med. Biol. 
511:57–70; discussion 70–73.


































dias,  cryptorchidism,  anogenital  distance,  and 
endocrine disruption. Curr. Urol. Rep. In press.
Downloaded on March 27, 2014.   The Journal of Clinical Investigation.   More information at  www.jci.org/articles/view/34241
